DAB2IP and urinary bladder cancer: In early studies with prostate and bladder cancer cell lines, DAB2IP knockdown increased resistance to ionizing radiation but rendered them sensitive to combined treatment with genotoxic drugs such as the bacterial cytolethal distending toxin (CdtB) or an ATM inhibitor [83, 84].